Views: 0 Author: Site Editor Publish Time: 2026-10-16 Origin: Site
RT40 Retatrutide Peptide: Latest Research Progress & Literature Reference for Metabolic Research

RT40 is our catalog number for Retatrutide, also known as LY3437943, a breakthrough synthetic triple receptor agonist peptide targeting GLP‑1R, GIPR and GCGR. Since its first publication in Cell Metabolism in 2022, this peptide has become one of the most widely studied tool compounds for endocrine and metabolic pathway research in academic labs and biotech institutes worldwide.
1. Core Research Mechanism
Different from dual agonists such as tirzepatide, Retatrutide can simultaneously activate three hormone receptors.
• GLP‑1R: Regulates glucose-dependent insulin release and satiety signaling
• GIPR: Enhances insulin response and participates in adipose tissue remodeling
• GCGR: Promotes hepatic energy expenditure and fatty acid oxidation
This triple activation mechanism makes RT40 a valuable research tool for exploring cross-talk between multiple incretin hormone pathways, adipocyte fibrosis, lipid metabolism and body composition regulation.
2. Latest Published Literature & TRIUMPH Program Research Update
The TRIUMPH series phase 3 trials are the most cited recent research for Retatrutide, with key findings published in The New England Journal of Medicine and The Lancet in 2026.
1. TRIUMPH‑1 (Obesity population research)
Up to 28.3% average body weight reduction after 80 weeks of observation; 45.3% subjects achieved ≥30% weight loss. This dataset is widely quoted for studying long-term metabolic adaptation under triple-agonist stimulation.
2. TRIUMPH‑2 (Type 2 diabetes related research)
Research focused on glycemic control and lipid profile changes in overweight diabetic populations, providing reference data for glucose homeostasis study.
3. TRIUMPH‑4 (Obesity combined with knee osteoarthritis model)
The study explored the connection between metabolic improvement and joint inflammation relief, expanding the research boundary of multi-system metabolic regulation.
Additional preclinical multi-omics research published in 2026 revealed that Retatrutide can remodel dysfunctional white adipose tissue, suppress lipogenesis and inflammatory fibrosis, and restore mitochondrial oxidative function. This paper provides new molecular evidence for researchers studying adipose tissue metabolism.
Main cited references for laboratory literature review:
1. Coskun T, et al. Discovery and preclinical characterization of LY3437943 (Retatrutide). Cell Metabolism, 2022.
2. Jastreboff AM, et al. Retatrutide for obesity. N Engl J Med, 2026.
3. Bellido V, et al. Retatrutide in adults with obesity and type 2 diabetes. The Lancet, 2026.
3. RT40 Product Information for Laboratory Research
Our RT40 Retatrutide peptide is manufactured via solid-phase peptide synthesis (SPPS), purified with preparative HPLC.
• Catalog No: RT40
• CAS: 2381089-83-2
• Purity: ≥99% HPLC
• Form: White to off-white lyophilized powder
• Storage: -20°C sealed, dry and away from light
• Grade: Research Grade Only
Every batch comes with complete testing documents: COA, HPLC chromatogram and MS spectrum to confirm molecular identity and purity. Consistent batch quality reduces experimental variation for your lab projects.
4. Available Services for Global Research Buyers
✅ Free sample for preliminary quality verification before bulk purchase
✅ Custom peptide synthesis and custom vial packaging support
✅ Low-temperature moisture-proof packing for safe worldwide shipping
✅ Flexible MOQ, fast production lead time for lab & bulk procurement
Important Disclaimer
RT40 Retatrutide peptide is FOR LABORATORY RESEARCH USE ONLY.
Not for human or veterinary injection, clinical treatment, food or cosmetic application. All trial data cited in this article comes from public scientific literature, only for biochemical research reference. End users are responsible for proper storage and laboratory handling.
What Research Has Been Done on DAMGO? Evidence, Applications, And Peptide Quality
What Happened To Amino Asylum Peptides? A 2026 Guide To The Reports And Safer Supplier Selection
Freeze-Dried Peptides Vs Non-Lyophilized Peptides for International Shipping
Systemin And Plant Notch Signaling: What Researchers Should Know About Peptide Defense Pathways
Top 5 Peptide Companies: A Practical Buying Guide for Research And Cosmetic Development
Peptides Vs Steroids: Key Differences, Safety Evidence, And Research Sourcing
Tirzepatide API Shortage Mitigation: A Practical Guide To Peptide Supplier Qualification